Humans

Accelerated Pancreatic Volume Loss as a Potential Pre-Diagnostic Imaging Biomarker for Pancreatic Cancer Risk Enrichment: An AI-Assisted Volumetric Study

Figure 1. Flow diagram of case selection and propensity score matching. — Figure 1. Flow diagram of case selection and propensity score matching.Flow diagram of case selection and propensity score matching.Nakahodo et al. · CC BY

Cancers

Abstract

Background/Objectives: Treatment for pancreatic ductal adenocarcinoma (PDAC) depends on early detection, yet most present at an inoperable stage. Focal pancreatic parenchymal atrophy (FPPA) is a prodromal imaging feature lacking objective quantification.

The paper

Jun Nakahodo, Wataru Ujita, Daichi Sadato,

Yuki Fukumura, Yuji Aoki, Masataka Kikuyama, Shinichiro Horiguchi, Mizuka Suzuki, Kazuro Chiba, Hiroki Tabata, Kensuke Hoshi, Ryogo Minami, Toshiro Iizuka, Terumi Kamisawa, Masanao Kurata,

Tokyo Metropolitan Komagome Hospital

Cancers · 21 Sep 2026 · CC BY

doi.org/10.3390/cancers18183062 PubMed 42795025

Proteomic organ clocks predict mortality but trail established physiological and epigenetic biomarkers
Aging Cell · 2 Oct 2026
Human abdominal organ volumes peak in midlife then decline
European Journal of Radiology · 4 Oct 2026